Riskpilot← Back to searchSign inGet full accessCATO PHARMA ApS
APSActiveCVR 33949596Bernstorffsvej 52Manufacture of medical and dental instruments and supplies · NACE 3250Est. 2011— employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
-43379.2%
Financial strength
Net profit 2024
DKK -2K
-5% vs 2023
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.